NCT06661759 Clinic-based and Technology-Supported Sleep Intervention for Pediatric Epilepsy
| NCT ID | NCT06661759 |
| Status | Recruiting |
| Phase | — |
| Sponsor | National Taiwan University Hospital |
| Condition | Epilepsy |
| Study Type | INTERVENTIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-11-19 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 150 participants in total. It began in 2024-11-19 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Sleep problems are more common and more severe in children with epilepsy. The purpose of this study is to develop and evaluate the effect of a clinic-based and technology-supported sleep intervention for improving sleep and health in children with epilepsy and their parents.
Eligibility Criteria
Inclusion Criteria: * Children aged between 1.5 and 9 years with a confirmed diagnosis of epilepsy. * Parents with sufficient Chinese language skills to fully comprehend the trial and complete questionnaires. Exclusion Criteria: * Children who are bedridden. * Children with a documented sleep disorder, such as obstructive or central sleep apnea and sleep-related movement disorders * Children with severe motor dysfunction that prevents accurate sleep-wake differentiation via actigraphy.
Contact & Investigator
Shao-Yu Tsai
PRINCIPAL INVESTIGATOR
National Taiwan University
Frequently Asked Questions
Who can join the NCT06661759 clinical trial?
This trial is open to participants of all sexes, aged 18 Months or older, up to 9 Years, studying Epilepsy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06661759 currently recruiting?
Yes, NCT06661759 is actively recruiting participants. Contact the research team at yshansung33@ntu.edu.tw for enrollment information.
Where is the NCT06661759 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06661759 clinical trial?
NCT06661759 is sponsored by National Taiwan University Hospital. The principal investigator is Shao-Yu Tsai at National Taiwan University. The trial plans to enroll 150 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.